The FDA has given Quidel clearance for its Sofia RSV Fluorescent Immunoassay for use on the Sofia 2 Fluorescent Immunoassay Analyzer in rapid respiratory syncytial virus infection detection. The assay, which also received a CLIA waiver, is indicated to be used in nasopharyngeal aspirate/wash and nasopharyngeal swab specimens from symptomatic pediatric patients.
Quidel secures FDA clearance, CLIA waiver for RSV assay on analyzer
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.